Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pleural Malignancy × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3224 Carcinoma, Non-Small-Cell Lung 3170 Small Cell Lung Carcinoma 489 Breast Neoplasms 374 Neoplasms 273 Adenocarcinoma of Lung 217 Colorectal Neoplasms 195 Melanoma 173 Prostatic Neoplasms 164 Mesothelioma, Malignant 164 Pancreatic Neoplasms 159 Brain Neoplasms 157 Head and Neck Neoplasms 148 Neoplasm Metastasis 146 Ovarian Neoplasms 133 Mesothelioma 131 Esophageal Neoplasms 127 Colonic Neoplasms 121 Stomach Neoplasms 118 Pleural Effusion, Malignant 103 NSCLC 103 Carcinoma, Renal Cell 93 Urinary Bladder Neoplasms 91 Disease 76 Sarcoma 75 Thymoma 68 Uterine Cervical Neoplasms 66 Motor Activity 63 Thoracic Neoplasms 61 Lung Diseases 61

Interventions

Ultraviolet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01673074 2020-04-08

HPPH and PDT for Pleural Malignancy

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Pleural Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡